Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Director/PDMR Shareholding - Replacement

8 Mar 2017 18:21

RNS Number : 9264Y
De La Rue PLC
08 March 2017
 

De La Rue plc

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

8 March 2017

De La Rue plc (the "Company") has been advised today by Equiom (Guernsey) Limited as Trustee of the De La Rue Employee Share Ownership Trust that on 7 March 2017, the Trustees made a market share purchase of 21,293 ordinary shares of 44 152/175p  in the capital of the Company, and on behalf of the Company, at a price of 625.5p per share, to satisfy the vesting of an award made to Martin Sutherland, Chief Executive Officer (for nil consideration), on 26 November 2014 and the subsequent sale of 10,028 of those shares at a price of 625.5p per share to cover tax and social security. The remainder of the shares (11,265) are being retained.

The notification below is provided in accordance with the requirements of the EU Market Abuse Regulations.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Martin Sutherland

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer (and PDMR)

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

De La Rue plc

b)

 

LEI

 

213800DH741LZWIJXP78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 44 152/175p

 

 

GB00B3DGH821

b)

 

Nature of the transaction

 

 

(i) Vesting of 21,293 ordinary shares of an award made in November 2014; and (ii) the subsequent sale of sufficient shares to cover tax and social security. The remainder of the shares (11,265) are being retained.

c)

 

Price(s) and volume(s)

 

 

 

Transaction

Price(s)

 

Volume(s)

Total

Vesting

 

Nil

21,293

Nil

Sale for tax

625.5p

10,028

£62,725.14

 

 

d)

 

Aggregated information

 

 

Transaction

Price(s)

 

Volume(s)

Total

Vesting

 

Nil

21,293

Nil

Sale for tax

625.5p

10,028

£62,725.14

 

 

e)

 

Date of the transaction

 

2017-03-07 (GMT)

f)

 

Place of the transaction

 

(i) Vesting: Outside a trading venue

(ii) Sale: London Stock Exchange (XLON)

 

Ed Peppiatt, Company Secretary

Contact Number: 01256 605343

8 March 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSAFAAFWSEFD
Date   Source Headline
9th Jul 20201:38 pmRNSHolding(s) in Company
8th Jul 20203:58 pmRNSDirector/PDMR Shareholding
6th Jul 20202:20 pmRNSResults of Capital Raising and General Meeting
3rd Jul 20202:31 pmRNSHolding(s) in Company
2nd Jul 20205:46 pmRNSHolding(s) in Company
1st Jul 202010:46 amRNSBlock listing Interim Review
23rd Jun 202011:48 amRNSHolding(s) in Company
17th Jun 20202:15 pmRNSPublication of Prospectus
17th Jun 20207:01 amRNSProposed Capital Raising
17th Jun 20207:00 amRNS2019/20 FULL YEAR RESULTS AND ANNUAL REPORT 2020
16th Jun 20207:00 amRNSSFO INVESTIGATION CLOSURE
1st Jun 20207:00 amRNSTRADING AND COVID-19 UPDATE
6th May 20207:00 amRNSFULL YEAR ANNOUNCEMENT DATE
27th Apr 20205:57 pmRNSDisclosure of Rights Attached to Equity Shares
1st Apr 202012:28 pmRNSTotal Voting Rights
31st Mar 20207:00 amRNSTrading Update
27th Mar 20209:31 amRNSHolding(s) in Company
24th Mar 202010:35 amRNSHolding(s) in Company
9th Mar 20205:28 pmRNSHolding(s) in Company
5th Mar 20205:44 pmRNSHolding(s) in Company
25th Feb 20205:48 pmRNSHolding(s) in Company
25th Feb 20207:00 amRNSTURNAROUND AND TRADING UPDATE
10th Feb 20202:00 pmRNSCHIEF FINANCIAL OFFICER APPOINTMENT
4th Feb 20206:05 pmRNSDirector Declaration
3rd Feb 20202:38 pmRNSTotal Voting Rights
29th Jan 20203:53 pmRNSHolding(s) in Company
24th Jan 202010:44 amRNSDirectorate Change
7th Jan 20205:13 pmRNSHolding(s) in Company
7th Jan 20205:09 pmRNSDirector/PDMR Shareholding
7th Jan 20205:05 pmRNSDirector/PDMR Shareholding
6th Jan 20204:58 pmRNSHolding(s) in Company
2nd Jan 202010:58 amRNSBlock listing Interim Review
2nd Jan 202010:52 amRNSTotal Voting Rights
19th Dec 20192:58 pmRNSDirector/PDMR Shareholding
16th Dec 201912:46 pmRNSDirector/PDMR Shareholding
4th Dec 20196:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20193:36 pmRNSHolding(s) in Company
2nd Dec 201910:07 amRNSTotal Voting Rights
29th Nov 20192:09 pmRNSDirector/PDMR Shareholding
28th Nov 20194:20 pmRNSDirector/PDMR Shareholding
26th Nov 20196:44 pmRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNS2019/20 HALF YEAR RESULTS
21st Nov 20193:00 pmRNSAdditional Listing
13th Nov 20193:03 pmRNSHolding(s) in Company
8th Nov 20194:56 pmRNSHolding(s) in Company
31st Oct 20195:05 pmRNSTotal Voting Rights
30th Oct 20197:00 amRNSTrading Update
14th Oct 20193:59 pmRNSCompletion of Sale of ID Business
7th Oct 20195:53 pmRNSHolding(s) in Company
7th Oct 20194:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.